Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 65862-497

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 65862-497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg/200 mg/300 mg (30 Tablet Bottle))

Package Label-principal Display Panel (600 mg/200 mg/300 mg (30 Tablet Bottle))
NDG 65862-497-30 is a package of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets containing 30 film-coated tablets. Each film-coated tablet consists of 600 mg of Efavirenz USP, 200 mg of Emtricitabine, and 300 mg of Tenofovir disoproxil fumarate, which is equivalent to 245 mg of tenofovir disoproxil. The package contains an alert box warning not to take certain medicines with this tablet. It is distributed by Aurobindo Pharma USA, Inc. and made in India. The package insert provides details regarding the recommended dosage and administration. It should be stored at 20° to 25°C (68° to 77°F) and dispensed only in the original container. The batch and expiry will be printed during coding.*
FDA Label Image

Efavirenz Chemical Structure (Efemtf Str1)

FDA Label Image

Emitricitabine Chemical Structure (Efemtf Str2)

FDA Label Image

Tenofovir Chemical Structure (Efemtf Str3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.